| abstract |
The invention discloses an in vivo enzyme, a preparation method thereof, and an application in inhibiting novel viruses. The preparation method comprises adding beneficial microorganisms to raw materials, and the beneficial microorganisms establish a microbial community antagonism mechanism in the body, and the microorganisms interact with the intestinal tract. Synergistic fermentation of flora produces endogenous interferon, which blocks the virus replication system and enhances immunity to inhibit various pathogenic microorganisms, including prion, spirochetes, mycoplasma, rickets , and variants of new viruses. The in vivo enzyme provided by the present invention artificially establishes an in vivo microbial dominant population in the microscopic world by establishing a microbial confrontation model, and selectively inhibits the invasion of other pathogenic microorganisms. The confrontation in the microscopic world will accelerate the immune system in the human body to produce antibodies to this virus, so that various viruses can coexist peacefully in the microscopic world, and the synergistic effect of various beneficial microorganisms will reduce the impact of cytokine storm on organs. |